Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age



Status:Active, not recruiting
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:6 - 16
Updated:4/21/2016
Start Date:May 2015
End Date:June 2016

Use our guide to learn which trials are right for you!

A Phase IIA, Open-Label, Safety and Pharmacokinetic Study of Diclofenac Capsules in Pediatric Subjects 6 to <17 Years of Age With Mild to Moderate Acute Postoperative Pain Following Elective Surgery

The purposes of this study are to evaluate the safety and tolerability and to model the
single-dose pharmacokinetic profile of diclofenac capsules low dose and high dose in
children ages 6 to <17 years experiencing mild to moderate acute postoperative pain.


Inclusion Criteria:

- Body weight ≥18 kilograms.

- Mild to moderate acute pain requiring treatment with analgesic medication.

- Willing to have blood samples taken for PK sampling using an indwelling catheter.

- Must be able to swallow capsules and can tolerate oral medication.

- For females: is not of reproductive potential (defined as premenarchal) or is
practicing an acceptable method of birth control

Exclusion Criteria:

- Severe acute pain

- Chronic analgesic or glucocorticoid use for any condition within 6 months before
dosing with study drug.

- Emergency surgery

- History of allergic reaction, hypersensitivity, or clinically significant intolerance
to diclofenac, aspirin, codeine, acetaminophen, or any NSAID

- History of peptic ulcer disease or a GI event (eg, perforation, obstruction, or
bleed) within 6 months before screening

- Current use of any medication that may cause a clinically significant drug
interaction when co-administered with diclofenac

- Current use of any medication that might affect the pharmacokinetics of diclofenac

- History of bleeding disorders .

- Developmental delay or behavioral problems that would make it difficult to assess
pain.

- Impaired liver function

- Clinically significant renal or cardiovascular disease

- Any medical condition that compromises ability to swallow, absorb, metabolize, or
excrete the study drug

- Previously received any investigational product or device within 30 days before
Screening or scheduled to receive an investigational device or another
investigational drug (other than that in this study) during the course of this study.

- Previous participation in this clinical study or currently taking diclofenac.
We found this trial at
5
sites
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Sheffield, AL
Click here to add this to my saved trials